Anti-SCD polyclonal antibody

Study objective: This was a prospective, pre-post, 13-year observational study documenting the multiyear implementation of an observation unit sickle cell pathway for patients with uncomplicated vaso-occlusive events. Methods: The sickle cell pathway begins with rapid triage to identify patients with uncomplicated vaso-occlusive events for immediate transfer to the observation unit and initiation of patient-controlled analgesia followed by repeated evaluations of pain and identification of other complications. Data were abstracted from the electronic medical record or observation unit database. The sickle cell pathway was initiated in April 2006. Major revisions of it were carried out in June 2009 (physician evaluation occurs in sickle cell pathway and only patient-controlled analgesia administration of medications) and October 2010 (multidisciplinary management and individual dosing). Results: Annual ED visits ranged between 287 and 528. The preimplementation hospital admission rate was 33% (123/368), 3-day return rate 16% (60/368), and 30-day return rate 67% (248/368). Refinements to the sickle cell pathway have resulted in a decrease in admission rate to 20% (258/1276); 3-day return rate, to 3.6% (46/1,276); and 30-day return rate, to 41% (525/ 1,276) for the past 3 years. Conclusion: The use of a sickle cell pathway for the treatment of uncomplicated vaso-occlusive events has been effective in providing rapid treatment and reducing hospital admissions. However, it was not only the intervention and its refinement that made the sickle cell pathway successful. With the Consolidated Framework for Implementation Research, it was discerned that outer setting factors of organizational commitment to the care of patients with SCD, inner setting factors of learning climate and leadership engagement, individuals, and process contributed to the success of the sickle cell pathway.

Vegetable oils (VO) that are used to substitute fish oil in aquafeeds may affect, not only the fatty acid composition, but also lipid metabolism and distribution. The present study was designed to investigate this issue in juvenile golden pompano Trachinotus ovatus fed eight diets formulated with typical VO with widely varying fatty acid compositions including coconut oil (CO), palm oil (PO), oil-tea camellia seed oil (OTO), olive oil (OO), canola oil (CNO), peanut oil (PNO), linseed oil (LO) and perilla oil (PFO), in comparison with fish fed fish oil (FO). After the 8-week feeding trial, fish fed the CO diet had the highest growth performance, and higher general antioxidant capacities in serum and liver than in fish fed the other VO. The crude lipid content in whole body and expression levels of fas were lower in fish fed the FO, PFO and LO diets, while lipid contents and expression levels of scd were higher in fish fed the OTO and PNO diets. Other than fish fed the PFO diet, the total lipid contents of liver in other fish fed the other VO diets were higher than that in fish fed the FO diet, with the highest contents in fish fed the OTO and OO diets. The expression levels of genes involved in fatty acid catabolism and transport, namely ppara, cpt1 and apoB100, were higher in fish fed diet PFO than in fish fed the other diets. Comparing the fatty acid compositions of tissues and diets showed that 18:1n-9, 18:3n-3 (ALA) and 22:6n-3 (DHA) were preferentially deposited in tissues of pompano, with DHA preferentially deposited in polar lipids rather than neutral lipids. However, excessive dietary ALA in PFO did not lead to increased deposition of ALA, but increased liver lipid content. The present study showed that dietary lipid sources had significant influences on growth performance and antioxidant capacity, as well as on lipid deposition. Low dietary 18:1n-9, high n-3 long-chain polyunsaturated fatty acids and an appropriate ratio of ALA/LNA (18,2n-6) could reduce lipid deposition in pompano tissues, especially liver.